BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 24647545)

  • 1. The Notch pathway is important in maintaining the cancer stem cell population in pancreatic cancer.
    Abel EV; Kim EJ; Wu J; Hynes M; Bednar F; Proctor E; Wang L; Dziubinski ML; Simeone DM
    PLoS One; 2014; 9(3):e91983. PubMed ID: 24647545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gamma-Secretase Inhibitor IX (GSI) Impairs Concomitant Activation of Notch and Wnt-Beta-Catenin Pathways in CD44
    Barat S; Chen X; Cuong Bui K; Bozko P; Götze J; Christgen M; Krech T; Malek NP; Plentz RR
    Stem Cells Transl Med; 2017 Mar; 6(3):819-829. PubMed ID: 28186678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Notch pathway activity identifies cells with cancer stem cell-like properties and correlates with worse survival in lung adenocarcinoma.
    Hassan KA; Wang L; Korkaya H; Chen G; Maillard I; Beer DG; Kalemkerian GP; Wicha MS
    Clin Cancer Res; 2013 Apr; 19(8):1972-80. PubMed ID: 23444212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GANT-61 inhibits pancreatic cancer stem cell growth in vitro and in NOD/SCID/IL2R gamma null mice xenograft.
    Fu J; Rodova M; Roy SK; Sharma J; Singh KP; Srivastava RK; Shankar S
    Cancer Lett; 2013 Mar; 330(1):22-32. PubMed ID: 23200667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Notch reporter activity in breast cancer cell lines identifies a subset of cells with stem cell activity.
    D'Angelo RC; Ouzounova M; Davis A; Choi D; Tchuenkam SM; Kim G; Luther T; Quraishi AA; Senbabaoglu Y; Conley SJ; Clouthier SG; Hassan KA; Wicha MS; Korkaya H
    Mol Cancer Ther; 2015 Mar; 14(3):779-787. PubMed ID: 25673823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Constitutive activation of signal transducer and activator of transcription 3 (STAT3) and nuclear factor κB signaling in glioblastoma cancer stem cells regulates the Notch pathway.
    Garner JM; Fan M; Yang CH; Du Z; Sims M; Davidoff AM; Pfeffer LM
    J Biol Chem; 2013 Sep; 288(36):26167-26176. PubMed ID: 23902772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HES1-mediated inhibition of Notch1 signaling by a Gemini vitamin D analog leads to decreased CD44(+)/CD24(-/low) tumor-initiating subpopulation in basal-like breast cancer.
    So JY; Wahler J; Das Gupta S; Salerno DM; Maehr H; Uskokovic M; Suh N
    J Steroid Biochem Mol Biol; 2015 Apr; 148():111-21. PubMed ID: 25541438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting epigenetic regulation of miR-34a for treatment of pancreatic cancer by inhibition of pancreatic cancer stem cells.
    Nalls D; Tang SN; Rodova M; Srivastava RK; Shankar S
    PLoS One; 2011; 6(8):e24099. PubMed ID: 21909380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quinomycin A targets Notch signaling pathway in pancreatic cancer stem cells.
    Ponnurangam S; Dandawate PR; Dhar A; Tawfik OW; Parab RR; Mishra PD; Ranadive P; Sharma R; Mahajan G; Umar S; Weir SJ; Sugumar A; Jensen RA; Padhye SB; Balakrishnan A; Anant S; Subramaniam D
    Oncotarget; 2016 Jan; 7(3):3217-32. PubMed ID: 26673007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crosstalk between the canonical NF-κB and Notch signaling pathways inhibits Pparγ expression and promotes pancreatic cancer progression in mice.
    Maniati E; Bossard M; Cook N; Candido JB; Emami-Shahri N; Nedospasov SA; Balkwill FR; Tuveson DA; Hagemann T
    J Clin Invest; 2011 Dec; 121(12):4685-99. PubMed ID: 22056382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of pancreatic cancer stem cell characteristics by α-Mangostin: Molecular mechanisms involving Sonic hedgehog and Nanog.
    Ma Y; Yu W; Shrivastava A; Srivastava RK; Shankar S
    J Cell Mol Med; 2019 Apr; 23(4):2719-2730. PubMed ID: 30712329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HES1 promoter activation dynamics reveal the plasticity, stemness and heterogeneity in neuroblastoma cancer stem cells.
    Riya PA; Basu B; Surya S; Parvathy S; Lalitha S; Jyothi NP; Meera V; Jaikumar VS; Sunitha P; Shahina A; Sukumaran R; Nair AS; Dhanesh SB; Jiffy J; Nelson-Sati S; Maliekal TT; Das AV; James J
    J Cell Sci; 2022 Nov; 135(22):. PubMed ID: 36321463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Function of Integrin-Linked Kinase in Modulating the Stemness of IL-6-Abundant Breast Cancer Cells by Regulating γ-Secretase-Mediated Notch1 Activation in Caveolae.
    Hsu EC; Kulp SK; Huang HL; Tu HJ; Salunke SB; Sullivan NJ; Sun D; Wicha MS; Shapiro CL; Chen CS
    Neoplasia; 2015 Jun; 17(6):497-508. PubMed ID: 26152358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hes1: a key role in stemness, metastasis and multidrug resistance.
    Liu ZH; Dai XM; Du B
    Cancer Biol Ther; 2015; 16(3):353-9. PubMed ID: 25781910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. α-Mangostin-encapsulated PLGA nanoparticles inhibit colorectal cancer growth by inhibiting Notch pathway.
    Chandra Boinpelly V; Verma RK; Srivastav S; Srivastava RK; Shankar S
    J Cell Mol Med; 2020 Oct; 24(19):11343-11354. PubMed ID: 32830433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TNFα enhances cancer stem cell-like phenotype via Notch-Hes1 activation in oral squamous cell carcinoma cells.
    Lee SH; Hong HS; Liu ZX; Kim RH; Kang MK; Park NH; Shin KH
    Biochem Biophys Res Commun; 2012 Jul; 424(1):58-64. PubMed ID: 22728043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting notch to eradicate pancreatic cancer stem cells for cancer therapy.
    Wang Z; Ahmad A; Li Y; Azmi AS; Miele L; Sarkar FH
    Anticancer Res; 2011 Apr; 31(4):1105-13. PubMed ID: 21508353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leptin-Notch signaling axis is involved in pancreatic cancer progression.
    Harbuzariu A; Rampoldi A; Daley-Brown DS; Candelaria P; Harmon TL; Lipsey CC; Beech DJ; Quarshie A; Ilies GO; Gonzalez-Perez RR
    Oncotarget; 2017 Jan; 8(5):7740-7752. PubMed ID: 27999190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant activation of Notch signaling in extrahepatic cholangiocarcinoma: clinicopathological features and therapeutic potential for cancer stem cell-like properties.
    Aoki S; Mizuma M; Takahashi Y; Haji Y; Okada R; Abe T; Karasawa H; Tamai K; Okada T; Morikawa T; Hayashi H; Nakagawa K; Motoi F; Naitoh T; Katayose Y; Unno M
    BMC Cancer; 2016 Nov; 16(1):854. PubMed ID: 27821106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oestrogen increases the activity of oestrogen receptor negative breast cancer stem cells through paracrine EGFR and Notch signalling.
    Harrison H; Simões BM; Rogerson L; Howell SJ; Landberg G; Clarke RB
    Breast Cancer Res; 2013 Mar; 15(2):R21. PubMed ID: 23497505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.